Proto Labs Inc (PRLB) valuation
Proto Labs P/E ratio history
Proto Labs trades at 48.2 times its earnings over the last twelve months and 29.2 times the earnings analysts expect over the next twelve. At its last 9 fiscal year ends its P/E ranged from 31.9 (year to Dec 2016) to 81.2 (year to Dec 2020), with a median of 53.4.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $50.59 | $0.88 | 57.5 | 30.6 |
| Dec 31, 2024 | $39.09 | $0.66 | 59.2 | 25.8 |
| Dec 31, 2023 | $38.96 | $0.66 | 59.0 | — |
| Dec 31, 2022 | $25.53 | -$3.77 | n/m | 19.7 |
| Dec 31, 2021 | $51.35 | $1.21 | 42.4 | 31.5 |
| Dec 31, 2020 | $153.40 | $1.89 | 81.2 | — |
| Dec 31, 2019 | $101.55 | $2.35 | 43.2 | — |
| Dec 31, 2018 | $112.79 | $2.81 | 40.1 | — |
| Dec 31, 2017 | $103.00 | $1.93 | 53.4 | — |
| Dec 31, 2016 | $51.35 | $1.61 | 31.9 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Proto Labs valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Proto LabsPRLB | $1.65B | 48.2 | 29.2 | 2.8 |
| Global IndustrialGIC | $1.66B | 19.5 | 19.4 | 1.2 |
| Werner EnterprisesWERN | $1.66B | — | 17.7 | 0.5 |
| Hub GroupHUBG | $1.64B | 15.4 | 12.4 | 0.4 |
| RedwireRDW | $1.67B | — | — | 3.9 |
| Distribution Solutions GroupDSGR | $1.62B | 184.1 | 21.3 | 0.8 |
| Healthcare Services GroupHCSG | $1.68B | 16.6 | 19.5 | 0.9 |
| TecnoglassTGLS | $1.71B | 13.6 | 12.9 | 1.6 |
| Icf InternationalICFI | $1.73B | 19.7 | 12.9 | 1.0 |
| Peer median | 18.0 | 17.7 | 0.9 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: PRLB financials · PRLB returns
No forecast, no recommendation. This page describes Proto Labs Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.